Document
Identifier
https://digitalrepository.uob.edu.bh/id/4955f492-4408-4366-9622-f6fef612f1df
Drug delivery of carvedilol (cardiovascular drug) using phosphorene as a drugcarrier : a DFT study
Linked Agent
Afzal, Q.Q, Author
Perveen, M, Author
Iqbal, J, Author
Akhter, M.S, Author
Nazir, S, Author
Al-Buriahi, M.S, Author
Alomairy, S, Author
Alrowaili, Z.A, Author
Country of Publication
Kingdom of Bahrain
Place Published
Sakhir, Bahrain
Publisher
University of Bahrain
Date Issued
2022
Language
English
Subject
English Abstract
ABSTRACT:
2D nanomaterial phosphorene is a chemistically stable, biocompatible, and biodegradable drug delivery platform. This study investigates the drug loading efficiency of phosphorene for the car-diovascular drug carvedilol using density-functional theory (DFT). In the gas phase, carvedilol prefers to interact with phosphorene via P-H bonding with an adsorption energy of 0.59 eV (0.45eV in water). The complex HOMO–LUMO energy gap has been calculated in gas and solvent media to assess phosphorene-carvedilol reactivity. As compared to free carvedilol and phos-phorene, the phosphorene-carvedilol complex has increased solubility. The NCI analysis visu-alises non-covalent interactions within complexes. The low Van der Waals interactions between carvedilol and phosphorene allow for easy drug offloading. The phosphorene-carvedilol com-plex is more soluble in water than previously thought. Phosphorene’s electron density changes significantly after complex formation, as revealed by charge decomposition plots and electron-localization function plots. PET (photo-induced electron transfer) analysis explains quenching.
Title of Periodical
Journal of Taibah University for Science
Member of
Category
Article